GB2072502A - Antitumour agent comprising lactobacillus casei - Google Patents

Antitumour agent comprising lactobacillus casei Download PDF

Info

Publication number
GB2072502A
GB2072502A GB8006639A GB8006639A GB2072502A GB 2072502 A GB2072502 A GB 2072502A GB 8006639 A GB8006639 A GB 8006639A GB 8006639 A GB8006639 A GB 8006639A GB 2072502 A GB2072502 A GB 2072502A
Authority
GB
United Kingdom
Prior art keywords
yit
cells
mice
mouse
negative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8006639A
Other languages
English (en)
Other versions
GB2072502B (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITUMOR AGENT
Yakult Honsha Co Ltd
Original Assignee
ITUMOR AGENT
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ITUMOR AGENT, Yakult Honsha Co Ltd filed Critical ITUMOR AGENT
Priority to GB8006639A priority Critical patent/GB2072502A/en
Publication of GB2072502A publication Critical patent/GB2072502A/en
Application granted granted Critical
Publication of GB2072502B publication Critical patent/GB2072502B/en
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8006639A 1980-02-27 1980-02-27 Antitumour agent comprising lactobacillus casei Granted GB2072502A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8006639A GB2072502A (en) 1980-02-27 1980-02-27 Antitumour agent comprising lactobacillus casei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8006639A GB2072502A (en) 1980-02-27 1980-02-27 Antitumour agent comprising lactobacillus casei

Publications (2)

Publication Number Publication Date
GB2072502A true GB2072502A (en) 1981-10-07
GB2072502B GB2072502B (ja) 1983-03-02

Family

ID=10511723

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8006639A Granted GB2072502A (en) 1980-02-27 1980-02-27 Antitumour agent comprising lactobacillus casei

Country Status (1)

Country Link
GB (1) GB2072502A (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135820A2 (en) * 1983-08-26 1985-04-03 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
EP0228861A2 (en) * 1985-12-19 1987-07-15 Kabushiki Kaisya Advance Agent for reducing the dimethylnitrosoamine level
EP0279618A2 (en) * 1987-02-20 1988-08-24 William Leslie Porter Improvements in probiotic-type products
WO1989011858A1 (en) * 1988-06-09 1989-12-14 Whitecliffe Laboratories Limited Treatment of immunodeficiency
EP0599479A2 (en) * 1992-11-24 1994-06-01 Institut Pasteur De Kyoto Lactobacillus used to enhance immunological functions
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135820A2 (en) * 1983-08-26 1985-04-03 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
EP0135820A3 (en) * 1983-08-26 1987-10-14 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
EP0228861A2 (en) * 1985-12-19 1987-07-15 Kabushiki Kaisya Advance Agent for reducing the dimethylnitrosoamine level
EP0228861A3 (en) * 1985-12-19 1988-01-13 Kabushiki Kaisya Advance Anticarcinogenic agents
EP0279618A2 (en) * 1987-02-20 1988-08-24 William Leslie Porter Improvements in probiotic-type products
EP0279618A3 (en) * 1987-02-20 1989-08-16 William Leslie Porter Improvements in probiotic-type products
AU609444B2 (en) * 1987-02-20 1991-05-02 William Leslie Porter Improvements in probiotic-type products
WO1989011858A1 (en) * 1988-06-09 1989-12-14 Whitecliffe Laboratories Limited Treatment of immunodeficiency
EP0599479A2 (en) * 1992-11-24 1994-06-01 Institut Pasteur De Kyoto Lactobacillus used to enhance immunological functions
EP0599479A3 (en) * 1992-11-24 1995-04-05 Pasteur Inst Kyoto Lactobacillus to improve immune functions.
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product

Also Published As

Publication number Publication date
GB2072502B (ja) 1983-03-02

Similar Documents

Publication Publication Date Title
US4347240A (en) Antitumor agent containing Lactobacillus casei YIT 9018
US4710379A (en) Intestinal microflora-improving agent
US4746512A (en) Anticariogenic or antiperiodontitic agent
Kato et al. Macrophage activation by Lactobacillus casei in mice
CA1322720C (en) Anticarcinogenic agents
EP0196042A2 (en) Antibiotic prepared from lysobacter sp. SC 14,067
EP1835021A1 (en) Novel strain conferring anti-disease properties to host and bacterial cell composition
CA1135640A (en) Anti-tumor substance and process for preparing the same
CN113621538B (zh) 一种嗜淀粉乳杆菌及其应用
GB2072502A (en) Antitumour agent comprising lactobacillus casei
US4209507A (en) Novel anti-tumor substance and preparation thereof
JPH0782158A (ja) 抗腫瘍剤
US4656037A (en) SPF-100 and process for the preparation thereof
US6342366B1 (en) Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli cultures
CN116024113A (zh) 一种经修饰的细菌及其制备方法和应用
JP2506314B2 (ja) 家禽・豚の敗血症の予防・治療剤及び飼料
JPS6011686B2 (ja) 新規な抗腫瘍剤
KR920005685B1 (ko) 유산균을 이용한 항 종양제
KR920000115B1 (ko) 신규 유산균
KR100319162B1 (ko) 비피두스균 분열촉진용 아제티딘 유도체 및 그 제조방법
JPS6330319B2 (ja)
RU2217493C2 (ru) Биопрепарат-пробиотик, способ его получения и штамм streptococcus faecium те-17 для получения биопрепарата-пробиотика для животных и птицы
CN117866839A (zh) 一株粪肠球菌xy7及其在制备抗炎和改善痛风食品药品中的应用
KR0183443B1 (ko) 연쇄상 구균으로부터 항종양 및 면역증가 활성성분의 제조방법
CN117384789A (zh) 一株戊糖片球菌ks5及其在制备抗氧化和抗衰老食品药品中的应用

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20000226